tradingkey.logo

ReShape Lifesciences Inc

RSLS

3.920USD

0.000
Fechamento 09/19, 16:00ETCotações atrasadas em 15 min
10.29MValor de mercado
PerdaP/L TTM

ReShape Lifesciences Inc

3.920

0.000
Mais detalhes de ReShape Lifesciences Inc Empresa
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Informações da empresa
Código da empresaRSLS
Nome da EmpresaReShape Lifesciences Inc
Data de listagemOct 06, 2016
CEOMr. Paul F. Hickey
Número de funcionários17
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 06
Endereço1001 Calle Amanecer
CidadeSAN CLEMENTE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92673
Telefone19494296680
Sitehttps://www.reshapelifesciences.com/obalon/
Código da empresaRSLS
Data de listagemOct 06, 2016
CEOMr. Paul F. Hickey
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
931.00K
83.65%
Europe
98.00K
8.81%
Australia
78.00K
7.01%
Rest of World
6.00K
0.54%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qua, 17 de set
Atualizado em: qua, 17 de set
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BMO Nesbitt Burns Inc.
0.04%
UBS Financial Services, Inc.
0.04%
Leonite Fund I LP
0.04%
FirstFire Global Opportunities Fund LLC
0.04%
Bigger Capital Funds, LP
0.03%
Outro
99.82%
Investidores
Investidores
Proporção
BMO Nesbitt Burns Inc.
0.04%
UBS Financial Services, Inc.
0.04%
Leonite Fund I LP
0.04%
FirstFire Global Opportunities Fund LLC
0.04%
Bigger Capital Funds, LP
0.03%
Outro
99.82%
Tipos de investidores
Investidores
Proporção
Investment Advisor
0.09%
Corporation
0.08%
Hedge Fund
0.06%
Individual Investor
0.02%
Outro
99.76%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
34
270.50K
11.34%
+257.74K
2025Q1
42
35.95K
1.85%
+23.58K
2024Q4
36
92.62K
3.05%
+33.67K
2024Q3
40
51.79K
41.95%
-7.67K
2024Q2
37
52.29K
38.14%
-3.61K
2024Q1
40
50.20K
37.62%
-6.41K
2023Q4
40
53.11K
38.38%
+43.81K
2023Q3
41
10.13K
39.05%
+5.49K
2023Q2
42
5.11K
36.27%
+1.18K
2023Q1
51
5.76K
66.25%
+4.13K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
UBS Financial Services, Inc.
2.23K
0.09%
+1.52K
+214.99%
Mar 31, 2025
Leonite Fund I LP
8.00K
0.34%
+8.00K
--
Feb 18, 2025
FirstFire Global Opportunities Fund LLC
8.00K
0.34%
+8.00K
--
Feb 18, 2025
Bigger Capital Funds, LP
6.40K
0.27%
+6.40K
--
Feb 18, 2025
District 2 Capital LP
6.40K
0.27%
+6.40K
--
Feb 18, 2025
Schneid (Yair)
1.50K
0.06%
-201.00
-11.84%
Sep 23, 2024
Dominion Capital LLC
1.01K
0.04%
--
--
Feb 18, 2025
Tower Research Capital LLC
389.00
0.02%
+355.00
+1044.12%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Data
Tipo
Proporção
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Sep 19, 2024
Merger
58→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Dec 22, 2022
Merger
50→1
Jun 15, 2021
Merger
3→1
Jun 15, 2021
Merger
3→1
Ver Mais
KeyAI